Semax Nasal Spray

Explore the Semax Nasal Spray product information from Bond Peptides, including the peptide’s scientific background, molecular identity and intranasal formulation. This page provides an educational overview of Semax and the research associated with this synthetic peptide, alongside important product and regulatory considerations.

What Is Semax?

Semax is a synthetic heptapeptide, meaning it is made up of seven amino acids. Its sequence is Met-Glu-His-Phe-Pro-Gly-Pro. It is structurally related to a fragment of adrenocorticotropic hormone (ACTH), specifically the ACTH 4–10 region, with a Pro-Gly-Pro sequence at its C-terminal end.

Semax has been investigated in scientific literature relating to neurological and neurobiological processes. However, findings from laboratory and animal studies should not be interpreted as proof of clinical effectiveness in humans. The strength and limitations of the available evidence need to be considered when evaluating claims about this compound.

Semax Nasal Spray: Understanding the Formulation

A nasal spray is a liquid formulation delivered through a spray device into the nasal cavity. Intranasal administration has been used in research involving Semax, and nasal formulations are discussed in scientific and regulatory literature concerning the peptide.

The formulation and device are important product characteristics. Concentration, total volume, ingredient list, storage requirements, spray output and batch documentation should be confirmed using the actual manufacturer or supplier documentation. These details should not be assumed from the product name or image alone.

For other products in this range, visit the Bond Peptides nasal spray category.

Semax Peptide: Scientific Background

Semax has been the subject of research examining neurological processes and potential biological activity. Some published studies have explored its effects in experimental models, while human research has also been reported, particularly in Russian-language scientific literature.

Research findings do not automatically establish that a product is safe or effective for a particular purpose. Study design, sample size, research setting, publication quality and independent replication all matter when interpreting the evidence. More research may be needed to establish the safety and effectiveness of Semax for specific clinical uses.

Semax and Selank: What Is the Difference?

Semax and Selank are distinct synthetic peptides that are sometimes discussed together because both have been investigated in intranasal formulations. They do not have the same amino-acid sequence or structural origin.

• Semax: A synthetic heptapeptide related to the ACTH 4–10 fragment.
• Selank: A synthetic heptapeptide derived from the tuftsin sequence.

For a separate overview, see the Selank Nasal Spray product page. The two compounds should not be treated as interchangeable.

Semax Product Information

This page identifies the product as Semax Nasal Spray. Before relying on any additional product specifications, consult the product label and supporting documentation.

• Product name: Semax Nasal Spray
• Compound: Semax
• Peptide sequence: Met-Glu-His-Phe-Pro-Gly-Pro
• Form: Nasal spray presentation
• Formulation details: Refer to the product label and manufacturer documentation
• Batch information: Refer to the relevant batch-specific documentation, where available

Do not assume that a stated peptide identity or labelled amount independently verifies the identity, concentration, purity or quality of a finished formulation. Those details require appropriate analytical and manufacturing documentation.

Quality and Documentation

When evaluating a peptide product, relevant documentation may include a batch-specific certificate of analysis, identity testing, analytical methods, formulation ingredients, manufacturing information and storage conditions. A certificate should be reviewed to understand what was tested, which batch it covers, the methods used and the laboratory responsible for the analysis.

For general information about the business and its published information, visit About Bond Peptides.

Regulatory and Safety Considerations

Semax is not an FDA-approved drug in the United States. The FDA has published a review of Semax-related bulk drug substances that discusses limitations in the available safety information, including insufficient clinical information to characterize safety for intranasal administration. Regulatory status can differ between countries, so readers should consult the relevant medicines regulator in their jurisdiction.

Research publications and historical use in another country do not establish approval, safety or effectiveness in every jurisdiction. This product information is not medical advice and should not be used to diagnose, treat, cure or prevent any disease. No dosing or administration guidance is provided.

For further regulatory context, consult the FDA’s Semax safety review and briefing document.

Frequently Asked Questions

What is Semax Nasal Spray?

Semax Nasal Spray refers to a nasal spray presentation containing Semax, a synthetic heptapeptide with the amino-acid sequence Met-Glu-His-Phe-Pro-Gly-Pro. Product-specific formulation details should be checked against the label and supporting documentation.

What is the amino-acid sequence of Semax?

The commonly reported sequence for Semax is Met-Glu-His-Phe-Pro-Gly-Pro. It is a synthetic peptide related to the ACTH 4–10 fragment.

Is Semax the same as Selank?

No. Semax and Selank are different synthetic peptides with different amino-acid sequences and structural origins. They should not be considered interchangeable.

Has Semax been studied scientifically?

Yes. Semax has appeared in scientific literature, including research involving neurological and neurobiological processes. The quality and limitations of individual studies should be assessed before drawing conclusions about clinical effects.

Is Semax approved by the FDA?

No. Semax is not FDA-approved for use in the United States. The FDA has also discussed limitations in the available safety information for proposed intranasal preparations.

Where can I find information about the product formulation?

Refer to the product label and relevant manufacturer documentation for verified information about ingredients, concentration, volume, storage and batch testing. Do not infer these specifications from the product name alone.

Important Disclaimer

This page is provided for general educational and product-identification purposes only. It does not constitute medical advice, a recommendation to use Semax, or a claim that the product is approved for human use. Regulatory requirements vary by country. Always consult the relevant regulatory authority and a qualified healthcare professional for questions about medicines and health-related decisions.